Cargando…
Evaluation of bleeding in patients receiving direct oral anticoagulants
Direct oral anticoagulants (DOACs) are recognized by evidence-based treatment guidelines as the first-line option for the treatment of venous thromboembolism and prevention of stroke and systemic embolism in nonvalvular atrial fibrillation. As use of these anticoagulants has become favored over the...
Autores principales: | Hellenbart, Erika L, Faulkenberg, Kathleen D, Finks, Shannon W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574591/ https://www.ncbi.nlm.nih.gov/pubmed/28860793 http://dx.doi.org/10.2147/VHRM.S121661 |
Ejemplares similares
-
Periprocedural Management of Direct Oral Anticoagulants Surrounding Cardioversion and Invasive Electrophysiological Procedures
por: Finks, Shannon W., et al.
Publicado: (2018) -
Minimizing bleeding risk in patients receiving direct oral anticoagulants for stroke prevention
por: Habert, Jeffrey Steven
Publicado: (2016) -
Management of Venous Thromboembolism: Recent Advances in Oral Anticoagulation Therapy
por: Finks, Shannon W., et al.
Publicado: (2016) -
Practical guidance on the use of laboratory testing in the management of bleeding in patients receiving direct oral anticoagulants
por: ten Cate, Hugo, et al.
Publicado: (2017) -
Management of bleeding in patients treated with direct oral anticoagulants
por: Levi, Marcel
Publicado: (2016)